Compare BDTX & BGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BDTX | BGH |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 148.1M | 297.0M |
| IPO Year | 2020 | N/A |
| Metric | BDTX | BGH |
|---|---|---|
| Price | $2.49 | $15.06 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $10.60 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 61.5K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.06% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.38 | N/A |
| Revenue | ★ $70,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.59 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.20 | $11.92 |
| 52 Week High | $4.94 | $14.50 |
| Indicator | BDTX | BGH |
|---|---|---|
| Relative Strength Index (RSI) | 33.50 | 45.84 |
| Support Level | $2.52 | $15.15 |
| Resistance Level | $2.69 | $15.32 |
| Average True Range (ATR) | 0.12 | 0.14 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 17.44 | 27.70 |
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
Barings Global Short Duration High Yield Fund is a diversified, closed-end management investment company. Its investment objective is to seek as high a level of current income as the Adviser determines is consistent with capital preservation.